SIRT3 and cardiac hypertrophy: Reduced levels of SIRT3 in human hearts are linked to hyperacetylation of mitochondrial proteins and disrupted energetic metabolism, leading to structural and functional alterations in the heart, ultimately contributing to cardiac hypertrophy and heart failure.